Literature DB >> 15096137

Cutaneous mastocytosis in children: a clinical analysis of 71 cases.

A E Kiszewski1, C Durán-Mckinster, L Orozco-Covarrubias, P Gutiérrez-Castrellón, R Ruiz-Maldonado.   

Abstract

OBJECTIVE: To characterize the clinical features, response to therapy, evolution and prognosis of cutaneous mastocytosis in children.
BACKGROUND: Mastocytosis in children, instead of being induced by a potentially oncogenic c-kit mutation, is probably a clonal disease with benign prognosis.
METHODS: The clinicopathological features, evolution and response to treatment were analysed in 71 children with mastocytosis.
RESULTS: There were 53 (75%) cases of urticaria pigmentosa, 12 (17%) cases of mastocytoma, and six (8%) cases of diffuse cutaneous mastocytosis. In 92% of cases disease onset was in the first year of life. There was a male predominance 1.8 : 1. Treatment did not modify the disease evolution. Eighty per cent of patients improved or had spontaneous resolution of the disease.
CONCLUSION: The most frequent clinical form of mastocytosis was urticaria pigmentosa followed by mastocytoma and diffuse cutaneous mastocytosis. Darier's sign was present in 94% of cases. A negative Darier's sign does not rule out mastocytosis. In contrast to adults, mastocytosis in children usually has a benign course making sophisticated or invasive diagnostic tests unnecessary. A classification of paediatric cutaneous mastocytosis is proposed.

Entities:  

Mesh:

Year:  2004        PMID: 15096137     DOI: 10.1111/j.1468-3083.2004.00830.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  15 in total

1.  Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.

Authors:  Melody C Carter; Sarah T Clayton; Hirsh D Komarow; Erica H Brittain; Linda M Scott; Daly Cantave; Donna M Gaskins; Irina Maric; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2015-06-01       Impact factor: 10.793

Review 2.  Current approach to cutaneous mastocytosis in childhood.

Authors:  Zeynep Tamay; Deniz Özçeker
Journal:  Turk Pediatri Ars       Date:  2016-09-01

Review 3.  Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Cem Akin
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 4.  Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Authors:  Mariana Castells; Dean D Metcalfe; Luis Escribano
Journal:  Am J Clin Dermatol       Date:  2011-08-01       Impact factor: 7.403

Review 5.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

6.  Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology.

Authors:  Ashraf Uzzaman; Irina Maric; Pierre Noel; Brett V Kettelhut; Dean D Metcalfe; Melody C Carter
Journal:  Pediatr Blood Cancer       Date:  2009-10       Impact factor: 3.167

Review 7.  Pediatric Mastocytosis: Recognition and Management.

Authors:  Julie V Schaffer
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

8.  Abnormal bone marrow histopathology in paediatric mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Alicia S Clark; Alan S Wayne; Irina Maric
Journal:  Br J Haematol       Date:  2014-11-28       Impact factor: 8.615

9.  Mastocytosis in children and adults: clinical disease heterogeneity.

Authors:  Magdalena Lange; Bogusław Nedoszytko; Aleksandra Górska; Anton Zawrocki; Michał Sobjanek; Dariusz Kozlowski
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

10.  Dermatoscopic findings in telangiectasia macularis eruptiva perstans.

Authors:  Natasha Unterstell; Fernanda Guedes Lavorato; Natália Solon Nery; Danielle Mann; Maria de Fátima Scotelaro Guimarães Alves; Carlos Barcauí
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.